Faculty
Claus Andersen
Denmark
Claus Andersen
Claus Yding Andersen is Scientific Director of Laboratory of Reproductive Biology, University Hospital of Copenhagen, Denmark and Professor of Human Reproductive Physiology, Faculty of Health and Medical Sciences, University of Copenhagen.
Professor Andersen was member of the team that introduced IVF to Denmark in the mid-1980s and has during the last 20 years headed a national program of cryopreservation of human ovarian and testicular tissue. He is considered one of the pioneers in this field.
Professor Andersen’s major research contributions are ovarian endocrinology, oocyte maturation, cryopreservation of gonadal tissue, human embryonic stem cells and development of new principles for ovarian stimulation including introduction of the agonist trigger and novel approaches to luteal phase support.
He has published more than 440 scientific papers. His current H-index is 80 (Google Scholar) with more than 22.000 citations and he has made numerous international presentations and is currently chief editor on the Reproduction section of Frontiers in Endocrinology (IF 5.5).
David Chan
Hong Kong
David Chan
Prof. David Yiu Leung CHAN (陳耀樑) is currently an assistant professor in CUHK, Department of O&G. He obtained his D.Phil in University of Oxford in 2011. He was trained as clinical embryologist in Queen Mary Hospital, University of Hong Kong in 2012. He joined CUHK as a Research Assistant Professor in 2016, certified as Senior Clinical Embryologist by European Society of Reproduction and Embryology (ESHRE) in 2019 and become the director of the IVF laboratories Unit in Prince of Wales Hospital in 2020. In 2022, he is the person of responsible of the Assisted Reproductive Centre in Chinese University of Hong Kong medical centre.
Dr. Chan’s research mainly focuses on human reproduction, human embryo development and advancement of Assisted Reproduction Technologies (ARTs). He has published over 40 international peer-reviewed journals and currently very active in IVF related clinical research. Dr. Chan obtained several external competitive grants, totally granted amount more than 10 million HKD since joining.
Carina Chan
Hong Kong
Carina Chan
Xiao Yan Chen
Hong Kong
Xiao Yan Chen
Dr. Xiaoyan Chen is the director of Maternal-Fetal Research Institute in Shenzhen Baoan Women’s and Children’s Hospital in China. She is also the adjunct Assistant Professor of the The Chinese University of Hong Kong. She has special interest in recurrent miscarriage, recurrent implantation failure, reproductive endocrinology and uterine structure and functions. She participated in the research and clinical application of uterine natural killer cell test. Dr. Chen has published over 40 papers in international peer-reviewed journals. She is also invited into the editorial board of international journals such as BMC pregnancy and childbirth.
Judy Chow
Hong Kong
Judy Chow
Dr Chow is currently the Technical Manager in the University of Hong Kong-Tsan Yuk Hospital Preimplantation Genetic Diagnosis Laboratory (HKU-TYH PGD Laboratory). She previously served as Senior Embryologist in the Department of Obstetrics and Gynecology, Queen Mary Hospital. In 2007, she established the Preimplantation Genetic Diagnosis Team in the department of Obstetrics and Gynecology, HKU and achieved the first live birth in Hong Kong after PGD for Huntington’s Disease. In 2011, she was awarded as the Young Investigator in the 8th Conference of the Pacific Rim Society for Fertility and Sterility. PGD team in HKU has already performed preimplantation genetic testing on > 100 genetic diseases. Recently, Dr Chow focus on the application of third generation sequencing in PGD.
Lai Ping Cheung
Hong Kong
Lai Ping Cheung
Dr. Cheung Lai‐ping, MBChB (CUHK), M.Med. (O&G) (Singapore), FHKAM(O&G), FRCOG(UK), FHKCOG, MBA(Health Care)(CUHK), MPH(CUHK), CERT HKCOG (Reprod Med), is the Consultant and Honorary Clinical Associate Professor at the Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong. She is also the Clinical Director of the Assisted Reproductive Technology Unit at the Prince of Wales Hospital. Besides as a medical doctor, she also has a dual degree in Master of Business Administration (Health Care) and Master of Public Health and is currently the Deputy Service Director (Quality and Safety) at the Prince of Wales Hospital. She became a Fellow of the Hong Kong Academy of Medicine (Obstetrics & Gynaecology) in 1996 and then accredited by the Hong Kong College of Obstetricians and Gynaecologists (HKCOG) to be a Subspecialist in Reproductive Medicine in 2002. Dr Cheung is also active within her professional college and has served in the Reproductive Medicine Subspecialty Board of the Hong Kong College of Obstetricians & Gynaecologists (HKCOG) since 2002. Her current research interests include ART and PCOS and she has published over 50 articles in various refereed journals.
Jacqueline Chung
Hong Kong
Jacqueline Chung
Dr. Chung Pui Wah, Jacqueline is an Associate Professor at the Department of Obstetrics and Gynaecology, the Chinese University of Hong Kong. She is the Deputy Director of the Assisted Reproductive Unit and the Deputy Director of the Pre-implantation Genetic Diagnosis Laboratory in the Chinese University of Hong Kong, Prince of Wales Hospital. She has published more than 70 peer reviewed journals and 5 book chapters. She was awarded the distinguished young fellow by the Hong Kong Academy of Medicine in 2018. She is a Council Member of the Hong Kong College of Obstetricians and Gynaecologists and the Honorary Secretary of the Reproductive Medicine Subspecialty Board. She is also the President of the Hong Kong Society for Reproductive Medicine and the local country representative for the Asia Pacific Initiative on Reproduction (ASPIRE). She devotes most of her time now in developing a dedicated clinic for fertility preservation at the Prince of Wales Hospital.
Ke Hui Cui
USA
Ke Hui Cui
Dr. Ke-Hui Cui graduated at Sun Yat-Sen University of Medical Sciences (SUMS), Guangzhou, China (technician 1975; M.D. 1982) and University of Adelaide, Australia (Ph. D. 1993). He set up the first prenatal genetic laboratory in China in 1976. He confirmed human X sperm are statistically larger than Y sperm in 1991. He won two times of Marion Merrell Dow Prize as first recognized leader of preimplantation genetic diagnoses (PGD) in the world in 1991, 94. The results showed 100% amplification and correct diagnoses without allete dropout after single cell biopsy from mice and human preimplantation embryos in sex determination, and human cystic fibrosis and sickle cell anaemia, and confirmed safety of PGD with mouse model. He verified that preimplantation genetic testing for aneuploidy or screening is neither scientific nor safe. He set up Hereditics in 2016, confirmed that cytoplasm is also very important hereditary material. Hereditics includes Genetics and Cytohetics.
Elvis Dong
Hong Kong
Elvis Zi Rui Dong
Dr. Elvis DONG, Assistant Professor, in Department of Obstetrics & Gynaecology, the Chinese University of Hong Kong. His main interests include development of low-pass genome sequencing based analytical tools for genomic study on maternal fetal medicine and human infertility genetics. Dr. Dong also focuses on studying the underlying repair mechanism(s) of chromosomal structural rearrangements (such as insertion) and the contributions to human diseases (such as position effect), particularly in male infertility. He is the PI of 8 competitive grants such as NSFC and HMRF, and the first/co-first/corresponding author in 16 articles published in peer-review journals. In addition, he has been invited to share his works in numerous international conferences. He is currently acting as Guest Editor in Genes and Frontiers in Genetics. His work is also recognized by the Outstanding Post-doctoral Fellow Presentation Award by the Association of Chinese Geneticists in America (United States).
Huai Liang Feng
USA
Huai Liang Feng
Dr. Feng has led the team to obtain more than 20 domestic and foreign patents, and obtained more than 30 scientific and technological achievement awards, published more than 200 peer-reviewed academic papers, and published five books; He is currently a distinguished professor and visiting professor in a number of Universities and Hospitals in American and China. He is also an academic committee member of several national and ministries key laboratories, and a member of the China NMPA Assisted Reproduction Standards Committee. On the basis of major theoretical and clinical researches on assisted reproductive medicine, the Institute of Reproductive Medicine he presides has laid out a full-chain solution of wanting to give birth to being able to give birth to eugenics.
Robert Fischer
Germany
Robert Fischer
Obstetric and gynaecologic training at the Department of Obstetrics and Gynaecology at the University Hospital of Münster, Germany (1979-1982).
1982 one year of obstetrics and gynaecology at the Queen‘s Medical Centre,
University of Nottingham (King’s Mill Hospital Mansfield).
1983 pioneered and medical director of the first outpatient IVF-unit in Germany – Hamburg.
1998 moved to new location in Hamburg and change the name to Fertility Center Hamburg, which became one of the largest and leading private IVF centres in Germany.
In July 1998 the Fertility Center Hamburg was one of the first centres in Germany and worldwide to introduce quality management to be certified according to the ISO 9001 and in 2002 accreditation of the IVF-Lab. (ISO 17025).
Numerous publications in national and international scientific journals, book articles as well as lectures on national and international conferences.
- Active member of the American Society of Reproductive Medicine (ASRM)
- Founding member of the European Society of Human Reproduction (ESHRE)
- Member of the scientific committee of EXCEMED (former-(Serono Symposia International Foundation)
- Founding member of the POSEIDON Group
- Scientific director of MEDEA
Norbert Gleicher
USA
Norbert Gleicher
Dr. Norbert Gleicher founded the Center for Human Reproduction (CHR) in 1981, after completing his residency at the Mount Sinai School of Medicine in New York and holding top academic and administrative positions in various academic institutions in New York and Chicago. Always keen on simultaneously pursuing clinical care and research, Dr. Gleicher has published hundreds of peer-reviewed medical journal articles, abstracts and book chapters, in addition to editing textbooks that are now regarded as classics. He also holds an appointment as Guest Investigator at Rockefeller University and Professor (Adj.) at Medical University Vienna.
Zhong Wei Huang
Singapore
Zhong Wei Huang
Zhongwei Huang, MBBS, PhD(Oxon), AFHEA (UK), MRCOG (UK), M.Med (O&G), FAMS (O&G), FAMS (Clinician-scientist), ABS(Diplomate)
Deputy Director, NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE) www.acrle.com
Deputy Director, Undergraduate Medical Education, Department of Obstetrics & Gynaecology, NUS Medicine
Adjunct Assistant Professor, Mechanobiology Institute, NUS
Research Clinician, Institute of Molecular and Cell Biology, A*STAR
Consultant, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics & Gynaecology, NUH
Dr Huang completed clinician scientist residency training in Obstetrics & Gynaecology and is currently a Consultant at the Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Infertility, National University Hospital, Singapore, subspecializing in Reproductive Medicine, IVF and Sexual Medicine. He completed his medical studies at the National University of Singapore and did his doctorate studies at the University of Oxford, United Kingdom, on human oocyte biology and fertility research. He is helming as Deputy Director of NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE), specialising in research for women’s reproductive health, ageing and digital medicine, and leading the conversation in women’s reproductive longevity and equality.
Kazuhiro Kawamura
Japan
Kazuhiro Kawamura
Dr. Kazuhiro Kawamura is a professor of Obstetrics and Gynecology of Juntendo University Faculty of Medicine. He received his medical and philosophy degrees from the Akita University School of Medicine. His OB/GYN and Reproductive Endocrinology and Infertility training was at the Akita University School of Medicine. He was also a Postdoctoral Fellow at Stanford University School of Medicine with Dr. Aaron JW Hsueh. In addition to teaching and clinical practice, he has published over 150 original articles in ovarian physiology and Reproductive Endocrinology and Infertility. He collaborated with Dr. Hsueh to establish an in vitro activation (IVA) method to treat infertility in patients with primary ovarian insufficiency (premature ovarian failure) and achieved successful pregnancies/deliveries. Now, he is studying to improve the clinical outcome of IVA using different approaches. He is also trying t rejuvenate oocytes/embryos from advanced-age women.
Joanne Kwak-Kim
USA
Joanne Kwak-Kim
Dr. Kwak-Kim is the Agnes D. Lattimer MD Professor of Obstetrics and Gynecology and Microbiology and Immunology, Chicago Medical School at Rosalind Franklin University of Medicine and Science, and the Director of Reproductive Medicine and Immunology at Rosalind Franklin University Health Clinic. Dr. Kwak-Kim’s keen interest lies in Reproductive Immunology, particularly recurrent pregnancy losses and repeated implantation failures, which have been the focus of her research. Her work in natural killer cells and Th1/Th2 immune responses in women with recurrent pregnancy losses and implantation failures is distinguished. The research work that she has done, which applies basic science techniques to clinical problems, is cutting edge. She has over 160 publications in peer-reviewed articles and books. Recently, she published a textbook, “Immunology of recurrent pregnancy loss and implantation failure.” Currently, she is the president-elect of ISIR and the chairman of the Fellow, Clinical Reproductive Immunology Board, American Society for Reproductive Immunology.
Shui Fan Lai
Hong Kong
Lai Shui Fan
Dr Lai Shui Fan is a reproductive medicine subspecialist currently working in Kwong Wah Hospital, Hong
Kong. She received her fellowship training in Kwong Wah Hospital and reproductive medicine subspecialty training in Queen Mary Hospital and Kwong Wah Hospital. She then obtained her Hong Kong College of Obstetricians and Gynaecologists subspecialist qualification in 2021. She is the Honorary Clinical Assistant Professor at the University of Hong Kong and the Chinese University of Hong Kong. In addition, she is also the committee member of the Hong Kong Society for Reproductive Medicine.
Her special interests are reproductive endocrinology, reproductive genetics and endometriosis.
Emily Lam
Hong Kong
Emily Lam
Dr Lam had her O&G training in the Prince of Wales Hospital, the Chinese University of Hong Kong, and then further sub-specialized in reproductive medicine there. She was admitted to the Doctor of Medicine (CUHK) in 2004. She has also spent 6 months in Nottingham (Queen’s Medical Centre) in 2005 for research training. She has published > 40 papers in peer-reviewed international journals. She is currently a committee member of the Hong Kong Society of Reproductive Medicine and works as the medical director in Victory A.R.T. laboratory (TST).
Milton Leong
Hong Kong
Milton Leong
Prof. Milton Ka Hong Leong was brought up in Hong Kong, finished his basic school years, and then went to attend McGill University in Montreal Canada. He did Honours Biochemistry as an undergraduate, and then Medical School. Further postgraduate training in Obstetrics and Gynecology followed, and he obtained his specialists degree in 1974. He then went to London on a McLaughlin Fellowship granted by the Canadian Royal College where he studied under Professors Richard Beard and Stuart Campbell. Returning to Montreal, he joined the McGill University Department as academic staff, and was active in teaching and also headed the High Risk Obstetric Unit.
In 1979 Prof. Leong returned to Hong Kong and engaged in private practice. Seeing a need at that time, he started to concentrate in the study and treatment of Infertility. He set up the IVF Centre at the Hong Kong Sanatorium and Hospital, a private hospital, in joint venture form, and with his partner Dr Clement Leung, they built it up to be one of the most successful IVF clinics in Asia and the world. He “made” and delivered the first IVF baby in Hong Kong in 1985,and in the last 20 years had researched, published, and taught the art and science of infertility and the assisted reproductive techniques.
Prof. Leong is a member of the various reproductive medicine societies, and various international committees. He lecture widely, and still plays an active academic role, and remains to be an Adjunct Professor of Obstetrics and Gynecology in McGill University. His current interest is how to provide the optimal treatment for infertile patients using a patient orientated, more holistic approach.
Raymond Li
Hong Kong
Raymond Li
Xiaoyan Liang
China
Xiaoyan Liang
- MD, Professor, Doctoral Supervisor, Chief Physician
- Founder of Reproductive Center, the Sixth Affiliated Hospital, Sun Yat-sen University
- Director of Department of Obstetrics and Gynecology, School of Medicine, Sun Yat-sen University
- Principal Scientist, Department of Obstetrics & Gynecology and Pediatrics, Sixth Affiliated Hospital, Sun Yat-sen University
- Chief Scientist, National Key R & D Program of Ministry of Science and Technology
- Deputy Group Leader of Endocrinology Group, Chinese Society of Obstetrics and Gynecology
- Standing Committee Member of Specialized Committee of Reproductive Medicine, Chinese Medical Doctor Association
- Standing Committee Member of Specialized Committee of Maternal and Child Health Care
- Member of Clinical Group, Chinese Society of Reproductive Medicine
- Medical Leading Talent in Guangdong Province
- 2014 ~ 2015 President of Global Chinese Society of Reproductive Medicine
- Prof Liang has published more than 150 papers in well-known journals such as Nature communication, edited “Assisted Reproductive Clinical Technology-Practice and Improvement“ and participated in the first and second editions of Chinese Obstetrics and Gynecology. She is responsible for more than 30 national and provincial natural science funds and health department funds, and as the chief scientist, she has obtained the key R & D plan of the Ministry of Science and Technology of the People’s Republic of China “Establishing an effective optimization system for in vitro maturation of human oocytes and safety research on their clinical application”. She participated in the development of national consensus on diagnosis and treatment of PCOS, hyperprolactinemia and amenorrhea.
- Created multiple first cases.
- 2002:Carried out IVM and gave birth to the first IVM baby in Guangdong Province.
- 2012:Carried out the first monozygotic twin ovarian tissue orthotopic transplantation in China.
- 2016:Created the first Fertility Preservation Bank in South China.
- 2017:Conducted the first implementation of the “intra-oocyte injection of autologous bone marrow cell mitochondria” technique for patients with egg quality defects in the world.
- 2021:Established “Guangdong Fertility Preservation Engineering Technology Research Center”, carried out the first frozen-thawed prepubertal ovarian tissue and autologous intraperitoneal transplantation technique in China and successfully induced pubertal development, as well as a optimized fertility preservation technique for in vitro maturation of eggs for ovarian cancer.
- 2022:Complete the first case of autogenousthawed ovarian tissue transplantation to induce puberty development in a girl with severe thalassemia and the case of testicular tissue freezing in a boy with severe thalassemia in China.
Kui Liu
Hong Kong
Kui Liu
Dr. Liu obtained his Ph.D. from Umeå University, Sweden in September 1999. After his postdoctoral period at Harvard Medical School, USA, he became an assistant professor in 2003 in Umeå University, Sweden. He became a professor in 2010 in Umea University and Gothenburg University, Sweden, and moved to the University of Hong Kong and University of Hong Kong Shenzhen Hospital in 2018. Ever since he established his own research group, he has been studying mechanisms of female germ cell development, especially for the topic of activation of primordial follicles. In the past years, his group has published papers in top journals such as Science, PNAS, Current Biology, Journal of Cell Biology, Cell Research and Nature Medicine. The studies published not only represent advances in basic research but also has the implication for translating into possible novel treatment of female infertility.
Jie Qiao
China
Jie Qiao
Professor QIAO Jie is Academician of Chinese Academy of Engineering, Vice President of China Association for Science and Technology, Executive Vice President of Peking University, President of Peking University Health Science Center, President of Peking University Third Hospital, Academician of American Academy of Arts and Sciences, Honorary Fellow of Royal College of Obstetricians and Gynaecologists. She is the Director of The National Clinical Research Center on Obstetrics and Gynecology (OBYGN) Disease, Vice President of Chinese Medical Association, President of China Women Doctors Association and etc.
For more than 30 years, Professor Qiao has been engaged in clinical, basic research and transformation related to maternity and reproductive health. She has led the team to achieve a number of technical and theoretical breakthroughs in infertility causes and clinical treatments, the protection and preservation of female fertility, the molecular mechanism of human gametogenesis and embryo development as well as developing new pre–implantation diagnosis methods, protecting the health of women and children throughout their life cycle. As the first or corresponding author, she published a number of achievements with international influence and won the Highlight Achievement Award in Science and Technology in 2014 and 2015, Top Ten Progress Awards in China’s Life Sciences in 2019, National Award for Progress in Science and Technology (Second Award), National Innovation Award and etc.
Gerald Schatten
USA
Gerald Schatten
Gerald Schatten is Professor and Vice-Chair of Obstetrics, Gynecology and Reproductive Sciences, Cell Biology, Bioengineering and Division Director of the Division of Developmental and Regenerative Medicine. Dr. Schatten has directly trained >50 doctoral and postdoctoral fellows, along with several MD, MD-PhD and DVM trainees. He is active in advanced research training and was the founding director of the FRONTIERS IN REPRODUCTION, the premier reproduction training vehicle for MD and PhDs. He is currently President of UNESCO’s International Cell Research Organization. With extensive funding from the National Institutes of Health, Dr. Schatten is the recipient of an NIH MERIT, and earlier a Research Career Development, Award, was honored by the Czech Academy of Sciences with their Purkinje Medal of Science, elected as a Fellow and later a Delegate of the American Association for the Advancement of Sciences, a Mentor Awardee of the American Society for Cell Biology, Elected Australian Society for Reproductive Biology President’s Lecturer, awarded the Daniel Mazia Award from Stanford University and a Doctor Honoris Causa (Honorary Doctorate) from the University of Nova Gorica, presented by the President of the Republic of Slovenia, among other honors. He is the 2019 Johan Gregor Mendel Lecture Awardee speaking at Mendel’s home, the Augustinian Abbey in Brno, Czech Republic. His > 300 papers on stem cells, regeneration, fertilization, cell biology, development, infertility, assisted reproductive technologies, as well as strategies for rectifying past injustices in scientific careers, have appeared in premier journals including Nature and Science. Dr. Schatten is also an eloquent advocate for research in reproduction, development, regeneration and stem cells. Prof. Schatten has just been awarded the NIH’s inaugural Outstanding Mentor for Excellence in Diversity, Equity, Inclusion, and Accessibility honoring him, among > 1600 nominees, as an ‘outstanding mentor who has demonstrated compelling commitments and contributions to enhancing DEIA in the biomedical sciences’.
Sherman Silber
USA
Sherman Silber
Dr. Sherman Silber, a renowned pioneer in microsurgery and infertility, is considered one of the world’s leading authorities on IVF, mini-IVF, sperm retrieval, ICSI, vasectomy reversal, male infertility, tubal ligation reversal, egg and embryo freezing, ovary transplantation and the reproductive biological clock.
For over 46 years Dr. Silber has originally developed all of the most popular fertility treatments used all around the world today.
He performed the world’s first microsurgical vasectomy reversal, as well as the first testicle transplant, in the 70’s and now in the current century, the world’s first ovary transplant. He was the first to develop the TESE and MESA techniques for retrieving testicular and epididymal sperm in azoospermic men. He headed the clinical MIT team that first mapped and sequenced the Y chromosome in infertile men and discovered the now famous DAZ gene for male fertility. His research includes also the study of reproduction and fertility in zoo animals and endangered species. Most recently he has perfected the preservation of fertility for cancer patients with ovarian freezing and transplantation and thereby figured out how to extend the reproductive biological clock of women. He has helped pioneer minimal ovarian stimulation to reduce IVF costs and eliminate complications while maintaining the very highest success rate, even in older women. He heads the clinical team on the CHOSE project to transform skin biopsy cells into eggs and sperm in humans. He has even recently answered the age-old question of why the dinosaurs went extinct by extending his research on male infertility and the Y chromosome, discovering that the change in earth temperature 65,000,000 years ago led to the birth of a skewed male/female sex ratio.
He now heads the clinical team on the CHOSE project to transform skin biopsy cells into eggs an sperm in humans.
Dr. Silber went to medical school at the University of Michigan, did post-graduate training at Stanford University, and then again at the University of Michigan. From 1967 to 1969, he provided medical care via the U. S. Public Health Service to Eskimos, Indians, and Aleuts. Then he taught at the University of Melbourne Medical School in Australia, and later at the University of California Medical School in San Francisco. He is a scientific collaborator at MIT in Cambridge, Massachusetts, at the Kato Clinic in Tokyo, and at the University of Kyushu in Japan, and is a full professor at the University of Amsterdam, and at Sun Yat Sen University Medical School in China. His major clinical medical practice is at St. Luke’s Hospital in St. Louis, Missouri.
Nathan Treff
USA
Nathan Treff
Dr. Treff received his PhD in Biochemistry from Washington State University in 2003 and performed postdoctoral fellowships in embryonic stem cell biology at the University of Wisconsin-Madison in 2004 and reproductive genetics at EMD Serono in 2005. He previously served as a Research Director at RMA of New Jersey for over 10 years. He is currently Board Certified (ABB) in Molecular Diagnostics as a High Complexity Laboratory Director, a cofounder and the CSO and Clinical Laboratory Director of Genomic Prediction, and an Associate Professor at Rutgers University. He also serves as a Senior Editor of Fertility and Sterility Science and JARG, has published over 100 peer reviewed papers in reproductive genetics, and has received 7 awards from the ASRM. His research on PGT has been reported on by the Wall Street Journal, New York Times, Forbes, Bloomberg, and the Economist, among other media outlets.
Tian Ren Wang
China
Tian Ren Wang
Honorary Assistant Professor, Department of Obstetrics and Gynecology, School of Clinical Medicine, University of Hong Kong, Hong Kong, China
Associate consultant, University of Hong Kong Shenzhen Hospital, Reproductive Medicine Center, Shenzhen, China
Biography: Dr. Tianren Wang received her M.D. degree at the China Meidcal University in 2009 and Ph.D degree at Peking University (Beijing China) in 2014. She completed her postdoctoral training at Yale School of Medicine in 2017. Dr. Wang was the recipient of the In-Training Research Award (2016) from Americian Society of Reproduction Meidicne and President’s Presenter Award(2017) from Society for Reproductive Investigation. Her clinical and research interest are female fertility preservation, mitpchondria and ovarian aging and embryo development. Dr. Wang is currently sharing her clinical work with research and she is conducting clinical and translational research projects, supported by the National Natural Science and Foundation of China. She has published more than 20 peer-reviewed papers in Nature Communications, Cell Stem Cell, Aging cells, Human Reproduction and other prestigious journals. She also serves as member of editorial board and reviewer for many academic journals including Frontiers in Endocrinology, Fertility and Sterility et al.
Alice Wong
Hong Kong
Alice Wong
Dr. Wong Yuen Kwan Alice graduated from University of Hong Kong in 1990 and then received training in O&G and Endocrinology in Kwong Wah Hospital and Queen Mary Hospital. She underwent her further training in Reproductive Medicine in Cardiff, Wales in 1997.
She started the service of the Assisted Reproductive Centre of Kwong Wah Hospital, Hong Kong in 1997, which was later renamed as Dr Stephen Chow Chun-kay Assisted Reproductive Centre in 2000. She was working as Consultant in Kwong Wah Hospital, and was the Responsible Person & Accredited Specialist of Kwong Wah Hospital’s Assisted Reproductive Centre until 2014.
She is now in private practice. At present, she is also Honorary Clinical Associated Professor of the Department of O&G, University of HK.
Her main interest is in the field of Reproductive Medicine, and with special interest in the area of endometriosis; poor ovarian reserve and fertility preservation.
Li Wu
China
Li Wu
Graduated from Anhui Medical University with a Ph.D degree in 2015, Dr. Li Wu, she as a post-doctoral fellow studied at Rosalind Franklin University of Medicine and Science in 2016. She has been working in the First Affiliated Hospital of the University of science and technology of China (Anhui Provincial Hospital). She as an IVF physician works on the reproductive center, and focus on the research of immunology related mechanism of recurrent implantation failure and recurrent pregnancy losses.
In 2021, she obtained the General project of National Natural Science Foundation of China. She has presided over the Youth program of National Natural Science Foundation of China in 2016 and the general project of the Anhui Provincial Natural Science Fund and successfully concluded the project.
In 2016, she participated the 13th Congress of the International Society for Immunology of Reproduction and the European Society for Reproductive Immunology, did an oral presentation and won the New Research Scholar Award; In the same year, she did the oral presentation at the 72nd Scientific Congress of the American Society for Reproductive Medicine, and won the only RISIG award; In 2017, he was invited to give an oral presentation in the 37th Annual meeting of the American Society for Reproductive and was awarded Travel Awards.
In recent years, she has published about 12 SCI papers as the first author and corresponding author. In 2021, she was certified as a diplomate in clinical reproductive immunology of American society for reproductive immunology.
Wen Pei Xiang
China
Wen Pei Xiang
Professor Xiang received her Ph.D. degree in Gynecology and Obstetrics in 2005 from Tongji Medical College of Huazhong University of Science and Technology. She was a visiting scholar at the University of Pittsburgh Medical Center from 2011 to 2013. She is a full professor at Huazhong University Science and Technology (HUST). Broadly, her research field lies in female infertility, reproductive endocrine diseases with a keen focus on oogenesis, POF and stem cells. Her team tries to explore the pathogenesis of premature ovarian failure, and to explore the effect and mechanism of stem cells on rescuing POF. She has published more than 50 papers in high-impact factor journals, such as Science Advances, J of Advanced Research, Antioxid Redox Signal, J Biol Chem, Aging-US, Human Reproduction, etc.
Email:[email protected]
Song Guo Xue
China
Song Guo Xue
XUE, SONG GUO,Ph. D,Associate Research Fellow, Clinical Embrologist,IVF Lab Director, Deputy Director of the Department of Center for Reproductive Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
In July 2006, he graduated from Shanghai Jiao Tong University School of Medicine with a doctoral degree. From July 2006 to November 2017, he was a senior embryologist in the Department of assisted Reproduction, Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. From November 2017 to present, he is Deputy Director and Laboratory Director of Center for Reproductive Medicine, Shanghai East Hospital, Tongji University School of Medicine.
Xue and his colleagues established human single sperm freezing method using Cryopiece/Cryopiece 2.0 and trained about half of China’s reproductive centers. Most of the embryologists love the Cryopiece 2.0 method for single sperm cryopreservation. Xue and his colleagues invented Cryoclea,a closed vitrification system for human eggs and embryos/blastocysts. The preliminary results of Cryoclean is compareable to open system and easily used. Xue and his colleagues developed a new flicking biopsy method using specially designed holding and inside-narrow biopsy pipettes for human blastocyst biopsy. The new biopsy protocol was more safe and easily handle.
Albert Yuzpe
Canada
Albert Yuzpe
M.D., FRCSC, Clinical professor, co-founder and co-director at Olive Fertility, Centre, Vancouver (Canada)
Prof. Yuzpe is an internationally renowned obstetrician and gynecologist. As Canada’s most senior Reproductive Endocrinologist, he has been involved in IVF for the past 31 years and in the field of infertility for the past 44 years.
Prof. Yuzpe has made an immeasurable contribution to the field of fertility in Canada and worldwide. He is known for his role in developing the fertility drugs clomiphene and human FSH, in introducing the use of the surgical procedure laparoscopy and for launching one of the first IVF clinics in Canada at the University Hospital at the University of Western Ontario in London Ontario. He pioneered the development of the emergency contraceptive pill, which is often referred to as “The Yuzpe method.”
Prof. Yuzpe has been the recipient of numerous awards. His distinguished career, and the innovations he brings to the field of reproductive health, continues through his work at Olive Fertility Centre, which has several offices located throughout Metro Vancouver.
Prof. Yuzpe with his team continue to be at the forefront of innovations in the field of reproductive health.
Jia Zhou
Hong Kong
Zhou Jia
Zhou Jia is the scientific director and chief embryologist of Prolivfic A.R.T. Center, Hong Kong. She is the council member of the Hong Kong Society of Reproductive Medicine and the chairman of the Hong Kong Association of Clinical Embryologists.
Click to view the full scientific program